Medication info

Sodium Chloride Glucose Injection Solution (1-2)

Prescription medicationIntravenous injection
Ingredient · strength
Glucose›33.3g / 1000mLSodium Chloride›3g / 1000mL
Manufacturer / importer
Daehan Pharmaceutical Co., Ltd.
Appearance
This medication is a colorless, transparent liquid filled in a glass or plastic container with a slight salty and sweet taste.
Packaging
500mL/pack
Approval status
Active

MFDS item code 197100021 · Notified 1971.09.14 · Insurance code 645100832

Summary

Main use
Correction of deficiencies through fluid and electrolyte replacement (e.g., dehydration) and energy supplementation
Who receives it
Adults · Children
Adult administration
Usually, 500~1,000mL is administered by intravenous infusion per dose to adults. The infusion rate is 300~500mL per hour (75~120 drops per minute). The dose and infusion rate may be adjusted as appropriate according to age, body weight, and symptoms.
Child administration
Children: 50~100mL per hour Newborns and premature infants: Do not administer by rapid infusion (100mL or more per hour).

Ingredients

Manufacturer
Daehan Pharmaceutical Co., Ltd.

Efficacy & effects

Correction of deficiencies through fluid and electrolyte replacement (e.g., dehydration) and energy supplementation

  • Dehydration
View approved original text

This medication is used to replenish fluids and electrolytes needed for dehydration or before and after surgery. It also helps to supply energy to the body.

How it is given

Adult administration

Usually, 500~1,000mL is administered by intravenous infusion per dose to adults. The infusion rate is 300~500mL per hour (75~120 drops per minute). The dose and infusion rate may be adjusted as appropriate according to age, body weight, and symptoms.

Child administration

Children: 50~100mL per hour Newborns and premature infants: Do not administer by rapid infusion (100mL or more per hour).

Precautions

This medication contains glucose, which can rapidly increase the consumption of thiamine (vitamin B1) in the body during intravenous administration. There is a risk of thiamine deficiency, so caution is required. This medication should not be used in patients with excessive fluid retention, storage dehydration, or low serum potassium levels. It should be administered carefully to patients with impaired kidney function, weak heart function, hyperosmolar dehydration, low urine output due to urinary obstruction, diabetes, and high serum chloride levels. Rapid large-volume administration of this medication can cause brain or lung edema, peripheral edema, acidosis, and excessive fluid retention in the body. The infusion rate should be adjusted slowly, especially in newborns or premature infants, as rapid administration may lead to signs of fluid overload. There is also a risk of thrombosis at the intravenous injection site, so caution is required. Blood glucose levels, serum electrolyte concentrations, and the body fluid balance status should be regularly tested and managed. During pregnancy, it should only be administered when the benefits outweigh the risks, as safety for the fetus has not been fully established. Administering this medication during delivery may cause hyperglycemia in the mother and hypoglycemia or metabolic acidosis in the newborn, necessitating careful consideration. Newborns, especially preterm or low-birth-weight infants, require close monitoring for blood sugar control as they may have difficulties. Rapid or prolonged dosing should be avoided in infants and the elderly, and extra caution should be taken to reduce circulatory burden in the elderly with weak heart or kidney function. In case of overdose, diuretics may be needed to remove excess fluid from the body. Before administration, the patient's skin and the devices used should be thoroughly disinfected, and the medication in a cold state should be warmed to body temperature before use. It should be used immediately after opening, and any unused medication should be discarded. During administration, intravenous injection should be done slowly. Additionally, to prevent air embolism, the medication containers should not be connected continuously for use.

Side effects

  • Cerebral edema
  • pulmonary edema
  • peripheral edema
  • acidosis
  • water intoxication
  • thrombosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. The storage temperature should be maintained at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

This medication is a colorless, transparent liquid filled in a glass or plastic container with a slight salty and sweet taste.

Package unit

500mL/pack

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.